SUCCINYLCHOLINE CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Succinylcholine Chloride patents expire, and what generic alternatives are available?
Succinylcholine Chloride is a drug marketed by Accord Hlthcare, Adaptis, Amneal, Amphastar Pharms Inc, Amring Pharms, Aspiro, Baxter Hlthcare Corp, Be Pharms, Breckenridge, Deva Holding As, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Intl Medication, Mankind Pharma, Meitheal, Micro Labs, Nexus, Organon Usa Inc, Sagent Pharms Inc, Somerset Theraps Llc, Umedica, Zydus Pharms, and Steriscience. and is included in twenty-eight NDAs.
The generic ingredient in SUCCINYLCHOLINE CHLORIDE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Succinylcholine Chloride
A generic version of SUCCINYLCHOLINE CHLORIDE was approved as succinylcholine chloride by ZYDUS PHARMS on May 4th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUCCINYLCHOLINE CHLORIDE?
- What are the global sales for SUCCINYLCHOLINE CHLORIDE?
- What is Average Wholesale Price for SUCCINYLCHOLINE CHLORIDE?
Summary for SUCCINYLCHOLINE CHLORIDE
| US Patents: | 0 |
| Applicants: | 26 |
| NDAs: | 28 |
| Finished Product Suppliers / Packagers: | 26 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| Clinical Trials: | 2 |
| Patent Applications: | 1,169 |
| Drug Prices: | Drug price information for SUCCINYLCHOLINE CHLORIDE |
| What excipients (inactive ingredients) are in SUCCINYLCHOLINE CHLORIDE? | SUCCINYLCHOLINE CHLORIDE excipients list |
| DailyMed Link: | SUCCINYLCHOLINE CHLORIDE at DailyMed |
Recent Clinical Trials for SUCCINYLCHOLINE CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rutgers, The State University of New Jersey | N/A |
| Avera Pharmaceuticals | Phase 1/Phase 2 |
Pharmacology for SUCCINYLCHOLINE CHLORIDE
| Drug Class | Depolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Depolarizing Blockade |
Medical Subject Heading (MeSH) Categories for SUCCINYLCHOLINE CHLORIDE
US Patents and Regulatory Information for SUCCINYLCHOLINE CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steriscience | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 217873-001 | Jul 9, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Accord Hlthcare | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 213705-001 | May 20, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Meitheal | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 214514-001 | Oct 19, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
